- •Implementation science is the systematic study of factors leading to sustained use of evidence-based interventions.
- •Implementation science frameworks can lend methodological rigor to studies of access to gynecologic cancer care.
- •The CFIR framework considers aspects of Innovation, Inner Setting, Outer Setting, Individuals, and Implementation Process.
- •We recommend moving past associational studies in favor of systematic assessment and correction of specific barriers to care.
Barriers to access to cancer care are profoundly threatening to patients with gynecologic malignancies. Implementation science focuses on empirical investigation of factors influencing delivery of clinical best practices, as well as interventions designed to improve delivery of evidence-based care. We outline one prominent framework for conducting implementation research and discuss its application to improving access to gynecologic cancer care.
Literature on the use of the Consolidated Framework for Implementation Research (CFIR) was reviewed. Delivery of cytoreductive surgery for advanced ovarian carcinoma was selected as an illustrative case of an evidence-based intervention (EBI) in gynecologic oncology. CFIR domains were applied to the context of cytoreductive surgical care, highlighting examples of empirically-assessable determinants of care delivery.
CFIR domains include Innovation, Inner Setting, Outer Setting, Individuals, and Implementation Process. “Innovation” relates to characteristics of the surgical intervention itself; “Inner Setting” relates to the environment in which surgery is delivered. “Outer Setting” refers to the broader care environment influencing the Inner Setting. “Individuals” highlights attributes of persons directly involved in care delivery, and “Implementation Process” focuses on integration of the Innovation within the Inner Setting.
Prioritization of implementation science methods in the study of access to gynecologic cancer care will help ensure that patients are able to utilize interventions with the greatest prospect of benefiting them.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Gynecologic Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Managing clinical knowledge for health care improvement.Yearb Med Inform. 2000; 09: 65-70https://doi.org/10.1055/S-0038-1637943/ID/JR27709-63
- Healthcare Providers’ vaccine perceptions, hesitancy, and recommendation to patients: a systematic review.Vaccines. 2021; 9https://doi.org/10.3390/VACCINES9070713
- Financial toxicity: a practical review for gynecologic oncology teams to understand and address patient-level financial burdens.Gynecol. Oncol. 2023; 170: 317-327https://doi.org/10.1016/j.ygyno.2023.01.035
- Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care.
- National Center for Advancing Translational Sciences.(Accessed February 20, 2023)
- A systematic review of the use of the consolidated framework for implementation research.Implement. Sci. 2016; 11https://doi.org/10.1186/S13012-016-0437-Z
- The updated consolidated framework for implementation research based on user feedback.Implement. Sci. 2022; 17https://doi.org/10.1186/S13012-022-01245-0
- NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer.(Published online. Accessed February 20, 2023)
- Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian Cancer: Society of Gynecologic Oncology and American Society of clinical oncology clinical practice guideline.J. Clin. Oncol. 2016; 34: 3460https://doi.org/10.1200/JCO.2016.68.6907
- Failure to rescue as a source of variation in hospital mortality for ovarian cancer.J. Clin. Oncol. 2012; 30: 3976-3982https://doi.org/10.1200/JCO.2012.43.2906
- Current quality of gynecologic Cancer Care in North America.Obstet. Gynecol. Clin. N. Am. 2019; 46: 1-17https://doi.org/10.1016/j.ogc.2018.09.001
- Are patients willing to travel for better ovarian cancer care?.Gynecol. Oncol. 2017; (Published online)https://doi.org/10.1016/j.ygyno.2017.10.018
- Strategies for “bloodless” surgery: the experience of cytoreductive surgery for peritoneal carcinomatosis in Jehovah’s witnesses.ANZ J. Surg. 2020; 90: 1953-1957https://doi.org/10.1111/ANS.16101
- Ethical outreach for rural cancer care in the United States: balancing access with optimal clinical outcomes.JCO Oncol Pract. 2023; (Published online January 23)https://doi.org/10.1200/OP.22.00629
- Factors predicting surgical effort using explainable artificial intelligence in advanced stage epithelial ovarian cancer.Cancers (Basel). 2022; 14https://doi.org/10.3390/CANCERS14143447
- Barriers and enablers of uptake and adherence to digital health interventions in older patients with cancer: a systematic review.J Geriatr Oncol. 2022; 13: 1084-1091https://doi.org/10.1016/J.JGO.2022.06.004
Published online: March 25, 2023
Accepted: March 16, 2023
Received in revised form: March 10, 2023
Received: February 24, 2023
© 2023 Elsevier Inc. All rights reserved.